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PRACTICAL APPLICATIONS
Enhancing Periodontal Health Through Regenerative Approaches
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Focused Clinical Question: Can emerging technologies for periodontal regeneration become clinical reality?
Summary: Emerging technologies are presenting options to hopefully improve the outcomes of regeneration in chal-
lenging clinical scenarios. Cellular allografts represent a current technology in which cells and scaffolds are being delivered
directly to the periodontal lesion. Recombinant human fibroblast growth factor 2 and teriparatide (parathyroid 1-34) have
each been tested in controlled prospective human randomized clinical trials, and both have been shown to have potential
for periodontal regeneration. These examples, as well as other emerging technologies, show promise for continued advance-
ment in the field of periodontal regenerative therapy.
Conclusions: At present, there are indications that emerging technologies can be used successfully for periodontal
regeneration. Case reports and clinical trials are being conducted with a variety of emerging technologies. However, many
are yet to be approved by a regulatory agency, or there is a lack of evidence-based literature to validate their expanded use.
Clin Adv Periodontics 2015;5:40-46.
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See related systematic review and consensus report in the Journal of Periodontology (February 2015, Vol. 86, No. 2s) at
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Background
Complete regeneration of the periodontium remains an elusive
goalwith current treatmentmodalities. A number of emerging
technologies are being examined that can improve the outcome
of periodontal regeneration. These include the application
of protein and peptide therapy, cell-based therapy, genetic
therapy, application of scaffolds, bone anabolics, and lasers.
Other novel approaches include: 1) therapies directed at
the resolution of inflammation; 2) therapies that take into
account the influence of the microbiome; 3) therapies
involving the local regulation of phosphate and pyrophos-
phate metabolism; and 4) approaches directed at harnessing
current therapies used for other purposes.
As emerging technologies, by definition, most of these
therapies lack high levels of evidence. Currently, there are
numerous human clinical trials in varying stages of comple-
tion that are attempting to delineate the best applications
of the emerging therapies.
Current clinical examples showcased in the body of this
report reveal that excellent periodontal defect resolution
can occur with a number of emerging technologies (Video 1).
Decision Process
Emerging science and technology and their implication in
periodontal wound healing provide promising alternatives
to enhance regenerative therapeutic outcomes.
The application of new protocols to treat periodontal
diseases is shaping the concept of individualized regenera-
tive therapy; identifying the complex and heterogenic influ-
ences relative to each patient is of critical value (Fig. 1).
This report is directed toward contributing to the collec-
tive effort currently undertaken by various groups to increase
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the understanding of emerging therapeutic alternatives that
couldpotentiate the ability topredictably restore normalperi-
odontal function and structure.
Today, the lessons learnedonwoundhealing andperiodon-
tal development incorporate gene, protein, and metabolite
data into dynamic biologic networks that include disease ini-
tiating, susceptibility, and resolvingmechanisms.These ongo-
ing efforts of describing the basic elements involved in the
regeneration of the periodontal organ have unraveled novel
pathways that could be targeted in the treatment of inflam-
matory periodontal diseases.
The potential for novel regenerative therapies is sup-
ported by five key promising technologies that assist the
processes of gathering comprehensive information and se-
lecting the optimal approach that will enhance each pa-
tient’s intrinsic regenerative capacity and help to define
what constitutes a long-term successful outcome (Fig. 2).
The availability of advanced diagnostic methods, the use
of three-dimensional imaging modalities, the increasing
access to optimized scaffold fabrication technology, and
new surgical protocols and tools that minimize trauma
and enhance wound healing are paving the road to a more
predictable future in periodontal regenerative sciences.
To illustrate the potential benefit of emerging regenerative
protocols, this report focuses on three unique approaches:
1) the use of systemic anabolic agents; 2) local delivery of
growth factors; and 3) cell therapy. Collectively, the avail-
able clinical evidence and the comprehensive understanding
of their mechanism of action supports their value and assists
the health care provider in the task of identifying those clin-
ical scenarios in which their use may be particularly benefi-
cial (Fig. 3). In the case of systemic bone anabolic agents,
such as teriparatide, the literature suggests that all patients
would likely benefit from the use of this novel approach.
Nonetheless, it is fair to suggest that patients with known
bonemetabolism issues, such as osteopenia or osteoporosis,
might benefit the most from this therapy. With regards to
recombinant human fibroblast growth factor (rhFGF), the
vast understanding of its mechanism of action positions
the local delivery of this factor as a promising emerging ther-
apy. Its role in enhancing periodontal cell proliferation and
migration suggests a benefit for tipping the scale in the direc-
tion of regeneration. Furthermore, its effects on favoring an-
giogenesis could help overcome or ameliorate challenging
clinical scenarios that are characterized by impaired wound
healing. Last, in the case of cellular allografts, these alterna-
tives tend to lend themselves to defects that do not have
much in the way of bony walls, which typically supply cells
during thewoundhealing.Examples of these types of defects
include 1- and 2-wall defects and furcation defects.
Although the early clinical testing of these therapies is
promising, its full potential and clinical significance in
wound-healing biology relevant to periodontal regenera-
tion requires the application of sound basic surgical prin-
ciples along with proper case selection.
Clinical Scenarios
All patients in the following clinical scenarios provided
written or oral informed consent prior to treatment.
Teriparatide
Apromising anabolic agent is teriparatide,1which is the com-
mercially available form of parathyroid hormone (PTH1-34).
Teriparatide consists of the first 34 amino acids of the PTH
molecule and is givenusing self-administereddaily subcutane-
ous injections to the thigh or abdomen. Its ability to promote
anabolic effects relies on low, intermittent doses. Teriparatide
acts on preosteoblasts to increase proliferation and also acts
indirectly on osteoblasts to decrease osteoblast apoptosis.
This results in bone formation. Figures 4 and 5 show two clin-
ical examples of patientswhohave received systemic teripara-
tide for 6 weeks after open flap debridement (OFD) surgery,
and it can be observed that bone formation was achieved at
12 months, especially in the furcation regions.
rhFGF-2
Another emerging approach to regeneration is the controlled
release, local delivery of growth factors, such as FGF-2.2-4
rhFGF-2 acts by binding heparin, which results in broad mi-
togenic andangiogenic actions. Similar toother commercially
available regenerative agents, rhFGF-2 also acts early in the
differentiation of osteoprogenitor cells to increase bone for-
mation. Figures 6 and 7 represent clinical and radiographic
evidence of two patients who received rhFGF-2 combined
with cellulose from an exploratory Food and Drug Admin-
istration Phase IIa study demonstrating that this growth fac-
tor and carrier significantly improved thepercentageofbone
fill compared with carrier alone at 36 weeks after treatment.
Cellular Allograft
Cell therapy has also been studied extensively as a valuable
therapeutic option in regenerative medicine.5,6 In the
FIGURE 1 Factors supporting the emergence of individualized periodontal
regenerative therapy.
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context of periodontal regeneration, the cells seeded
into periodontal defects should be easy to harvest, non-
immunogenic, and highly proliferative and have the ability
to differentiate into the various types of cells comprising
the periodontal tissues. Adult mesenchymal stem cells
can become osteoblasts, fibroblasts, and cementoblasts.
In turn, these cells can all accelerate and enhance peri-
odontal wound healing and aid in periodontal regeneration.
Figures 8 and 9 show two clinical examples of patients who
received a commercially available allograft cellular bone
matrix.
Discussion
Periodontal diseases affect a large proportion of the popu-
lation, and the desire to restore health through regenerative
approaches has been hampered by the technical difficulties
and often unpredictable outcomes. Traditionally, the cur-
rent standard of care has allowed for the identification, di-
agnosis, and treatment of patients with periodontal disease
based on distinct clinical features that support a common
treatment protocol. However, the clinical reality reflects
a heterogeneity and complexity of factors that influence
wound healing.
Current advances in science and technology will enable
clinicians to seek a more comprehensive understanding of
the processes that occur within the susceptible patient’s
periodontium that favor the initiation and progression of
disease and will allow an individualized approach based
on biologically driven therapies that could help overcome
existing challenges.
FIGURE 2 Pivotal emerging science and tech-
nology supporting future periodontal regenerative
therapeutic protocols. 2D ¼ two-dimensional;
3D ¼ three-dimensional.
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FIGURE 4 A 45-year-old female former smoker.
Radiographic evidence of new bone formation
for tooth #3 suggesting periodontal regeneration
in the area of the furcation after OFD surgery
in conjunction with teriparatide treatment (case
courtesy of JDB). 4a Day of surgery. 4bOne-year
postoperative reevaluation. 4c Digital subtraction
radiography of before and after. Arrows localize
the enhanced signal reflective of new bone
formation.
Figs. 6 and 7)
FIGURE 3 Decision tree model. An emerging
treatment algorithm for the selection of viable
therapeutic options.
FIGURE 5 A 48-year-old male current smoker
(half pack per day). Radiographic evidence of
new bone formation for tooth #18 suggesting
periodontal regeneration in the area of the
furcation after OFD surgery in conjunction with
teriparatide treatment (case courtesy of JDB). 5a
Day of surgery. 5b One-year postoperative
reevaluation. 5c Digital subtraction radiography
of before and after. Arrows localize the enhanced
signal reflective of new bone formation.
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Therefore, deciphering the biologic phenotype that
determines tissue function and structure within an indi-
vidual is important.7 Acknowledging and incorporating
this information as clinicians will support not only the
emergence of novel therapeutic targets but also better
individualized methods to promote successful regener-
ative periodontal therapy.
Conclusions
Today’s challenges facing periodontal regenerative ther-
apy continue to stimulate important research and clinical
development, which, in turn, shape the current concept of
periodontal tissue engineering. Most of the protocols il-
lustrated in this report are under development and not
currently available for this specific application. How-
ever, it is already clear that these emerging technologies,
such as stem cell therapy, local delivery of growth fac-
tors, and bone anabolic agents, offer unique opportuni-
ties to enhance the predictability of current regenerative
surgical approaches and inspire development of novel
treatment strategies. Nonetheless, even with these
emerging technologies, basic surgical skills of excellent
flap management and proper root preparation are par-
amount to obtaining a successful regenerative out-
come. n
FIGURE 6 A 41-year-old female diagnosed with
chronic periodontitis. She had no smoking habit
and no systemic complications. Radiographic
and clinical evidence of new bone formation for
tooth #21 suggesting periodontal regeneration
after 9 months of local delivery of 0.3% rhFGF-2/
cellulose into a periodontal defect (case courtesy
of Drs. M. Ninomiya and T. Nagata, Tokushima
University, Tokushima, Japan). 6a through 6d
Standardized periapical radiographs before sur-
gery (6a) and at the 3-month (6b), 6-month (6c),
and 9-month (6d) reevaluations. 6e and 6f The
periodontal defect observed at baseline (6e)
contrasted with the evidence of bone fill at
clinical reentry (6f).
FIGURE 7 A 52-year-old female non-smoker.
Radiographic and clinical evidence of new bone
formation for tooth #3 suggesting periodontal
regeneration after 9 months of local delivery of
0.3% rhFGF-2/cellulose into the furcation and
vertical periodontal defect. The baseline radio-
graph shows vertical bone loss on the mesial
side and the furcation area (case courtesy of
SM). 7a through 7d Standardized periapical
radiographs before surgery (7a) and at the 3-
month (7b), 6-month (7c), and 9-month (7d)
reevaluations. 7e and 7f The advanced furcation
lesion observed at baseline (7e) contrasted with
the evidence of bone fill at clinical reentry (7f).
Figure 7 was previously published in Clinical
Advances in Periodontics.4
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FIGURE 9 A healthy 57-year-old female with significant periodontal breakdown on tooth #22 (case courtesy of BSM). 9a After flap reflection and
degranulation, the periodontal breakdown can be seen. 9b The cellular allograft## containing mesenchymal stem cells and osteoprogenitor cells was added to
the defect. 9c Periodontal osseous healing on the mesial aspect of tooth #22 can be seen coronal to the original native bone at 4 months after graft placement
when the site was entered for implant placement.
FIGURE 8 A healthy 55-year-old female with 9-mm
probing depths and Class II furcation involvement on
the lingual aspect of tooth #31 (case courtesy of
BSM). 8a Preoperative radiograph showing bone
loss in the furcation. 8b and 8c The extensive size of
the periodontal defect can be visualized after flap
reflection.8dThecellular allograft‖‖ containingmesen-
chymal stem cells and osteoprogenitor cells was
delivered into the periodontal defect. 8e A 6-month
two-dimensional radiograph and three-dimensional
cone-beam computed tomorgraphy{{ (CBCT) view
of the site after 3 years suggests significant bone fill.
Color dotted lines on the cross-sectional radiograph
assist location of the coronal and axial views from the
CBCT. 8f and 8g Axial and coronal slices from a 3-
year postoperative CBCT reflect complete bone fill of
the furcation and supportive evidence of a normal
periodontal ligament space (5  5 cm scan set at
90-mm resolution). Figures 8a, 8c, and 8d reproduced
with permission from Quintessence (McAllister6).
‖‖ Osteocel, ACE Surgical Supply, Brockton MA.
{{ CS 9300 CBCT system, Carestream Health, Rochester, NY.
## Osteocel, ACE Surgical Supply.
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